The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
Here's a technical look at how to trade five stocks trading for less than $10 a share.
In recent trading, shares of Sequenom Inc have crossed above the average analyst 12-month target price of $1.18, changing hands for $2.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Rigrodsky & Long, P.A.
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, and Sequenom, Inc.
Stocks with insider trader activity include KSU, TLMR and SQNM
Shares of the urology company surge in postmarket trading Thursday.
Stocks with insider trader activity include SQNM, OFIX and CIEN
Insiders at these companies have been busy buying.
Trade-Ideas LLC identified Sequenom (SQNM) as a strong on high relative volume candidate
Investors in Sequenom Inc saw new options begin trading this week, for the June 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Insiders at these companies have been scooping up shares of their own stock lately.
Trade-Ideas LLC identified Sequenom (SQNM) as a strong on high relative volume candidate
Trade-Ideas LLC identified Sequenom (SQNM) as a strong on high relative volume candidate
Investors in Sequenom Inc saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SQNM options chain for the new August 21st contracts and identified one put and one call contract of particular interest.
The most recent short interest data was recently released by the NASDAQ for the 05/15/2015 settlement date, and Sequenom Inc is one of the most shorted stocks of the Russell 3000, based on 7.20 "days to cover" versus the median component at 5.60. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Investors in Sequenom Inc saw new options begin trading this week, for the December 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 221 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Cramer likes Oshkosh Truck but isn't crazy about Genworth Financial.
Add them together and you've got a perfect recipe for the markets.
Investors considering a purchase of Sequenom Inc stock, but tentative about paying the going market price of $3.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $2.50 strike, which has a bid at the time of this writing of 17 cents.
The most recent short interest data was recently released by the NASDAQ for the 02/13/2015 settlement date, and Sequenom Inc is one of the most shorted stocks of the Russell 3000, based on 20.73 "days to cover" versus the median component at 5.17. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Investors considering a purchase of Sequenom Inc shares, but tentative about paying the going market price of $3.69/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $3 strike, which has a bid at the time of this writing of 25 cents.
The S&P 500 inched to another record high Wednesday after the release of the Federal Reserve's Beige Book showed the economy is still gaining strength.
U.S. stocks are trading just shy of record highs on Wednesday as energy stocks lead gainers and shake off recent tumbling commodity prices.
Sequenom (SQNM) shares are up after the company settled its patent dispute with rival Illumina (ILMN) today.
Illumina, Inc. (NASDAQ: ILMN) and Sequenom, Inc.
Investors eyeing a purchase of Sequenom Inc shares, but cautious about paying the going market price of $2.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $1.50 strike, which has a bid at the time of this writing of 25 cents.
Sequenom (SQNM) shares climbed nearly double digits following news that it had gained pre-market clearance from the FDA for its IMPACT genotyping test.
